Amgen recalls nearly one million heart and kidney medication bottles after unexpected foreign matter turned up on tablets. The voluntary drug recall covers 944,142 bottles of Corlanor and Sensipar. If you take either drug, check your bottle before your next refill.
Key Takeaways
- Amgen, Inc. recalled 944,142 bottles of Corlanor (ivabradine) and Sensipar (cinacalcet hydrochloride).
- The FDA rated it a Class II recall. No patient complaints have been reported.
- Affected tablets were distributed from Oct. 28, 2021, to Dec. 30, 2025.
What Happened at Amgen’s Packaging Site?
Amgen is a California-based biotech company headquartered in Thousand Oaks. Inspectors found foreign matter in a reserve sample from one lot. The material sat on the outside of the tablet, over the coating.
The issue was traced to the AML Building 23 packaging area. Amgen is recalling all lots within expiry processed there, not just the one lot with the defect.
Recall at a Glance
| Detail | Information |
|---|---|
| Company | Amgen, Inc. (Thousand Oaks, Calif.) |
| Products | Corlanor and Sensipar tablets |
| Total Bottles | 944,142 |
| Reason | Unexpected foreign matter on tablet surface |
| Source Location | AML Building 23 packaging area |
| FDA Classification | Class II |
| Complaints Reported | None |
| Recall Type | Voluntary, nationwide |
Intercon Chemical Co Hand Soap Recall: FDA Alert Explained
Which Bottles Are Affected?
The recall covers six presentations across two brands. Each one has a unique National Drug Code (NDC), a 10-digit number printed on the label. Match this number to confirm whether your bottle is included.
| Brand | Generic Name | Strength | Bottle Count | NDC |
|---|---|---|---|---|
| Corlanor | Ivabradine | 5 mg | 60 tablets | 55513-800-60 |
| Corlanor | Ivabradine | 5 mg | 14 tablets | 55513-800-99 |
| Corlanor | Ivabradine | 5 mg | 60 tablets | 55513-810-60 |
| Sensipar | Cinacalcet hydrochloride | 30 mg | 30 tablets | 55513-073-30 |
| Sensipar | Cinacalcet hydrochloride | 60 mg | 30 tablets | 55513-074-30 |
| Sensipar | Cinacalcet hydrochloride | 90 mg | 30 tablets | 55513-075-30 |
Who Takes Corlanor and Sensipar?
Both drugs treat chronic conditions, so many patients take them daily. That makes this recall personal for a large group of Americans.
| Drug | Generic Name | Primary Use | Patient Group |
|---|---|---|---|
| Corlanor | Ivabradine | Lowers heart rate | Adults with chronic heart failure |
| Sensipar | Cinacalcet hydrochloride | Controls parathyroid hormone | Chronic kidney disease patients, including those on dialysis |
Health Agencies Warn Consumers About Contaminated Cheese and Baby Wipes
How Serious Is an FDA Class II Recall?
The FDA sorts recalls into three classes by risk level. An FDA Class II recall sits in the middle tier. Our analysis suggests this rating reflects a precautionary move, not an urgent safety threat.
| Recall Class | Risk Level | What It Means |
|---|---|---|
| Class I | High | Reasonable chance of serious harm or death |
| Class II | Moderate | May cause temporary or reversible health effects; serious harm is remote |
| Class III | Low | Unlikely to cause any adverse health effect |
Amgen’s hazard assessment found no clinical risk to patients. The company rated the overall patient safety risk as low.
Why Recall Every Lot for One Bad Sample?
Industry insiders are noting that site-wide recalls are a standard response when the source of contamination is a shared facility. A single defect can signal a process-level problem.
- One reserve sample showed the foreign substance in tablets.
- All lots from the same packaging area carry the same exposure risk.
- Pulling every lot removes doubt for pharmacies and patients.
- Four years of distribution means many bottles are likely already used.
If you’ve been following prescription medication safety trends, this won’t come as a surprise. Manufacturers often over-recall to protect trust.
How Are Viruses Different From Bacteria Apex
Recall Timeline
| Date | Event |
|---|---|
| Oct. 28, 2021 | First affected tablets distributed |
| Dec. 30, 2025 | Last affected tablets distributed |
| 2026 | Foreign matter found in a reserve sample |
| Summer 2026 | Voluntary recall issued; FDA assigns Class II status |
| July 21, 2026 | Recall remains active; no complaints on record |
What Should Patients Do Now?
Your health routine matters more than panic here. Both drugs manage ongoing conditions, and stopping suddenly carries its own risks.
- Check the label on your bottle for the brand name and NDC number.
- Compare it against the six NDC codes listed above.
- Keep taking your medication unless your doctor tells you otherwise.
- Call your pharmacist to ask about a replacement supply.
- Contact your prescriber if you notice anything unusual on your tablets.
- Report side effects to the FDA’s MedWatch program.
Quick Action Guide
| Your Situation | Recommended Action |
|---|---|
| NDC matches the recall list | Contact your pharmacy for a replacement |
| NDC does not match | No action needed |
| Tablets look unusual | Stop and call your doctor before the next dose |
| Unsure about your bottle | Bring it to your pharmacist for a check |
What Does This Mean for Amgen?
Amgen holds a strong reputation in biotech manufacturing. This Class II action is contained, with no reported injuries. Still, a recall touching nearly one million bottles puts quality control under the spotlight.
- Patient impact: Low, based on current hazard assessments.
- Pharmacy impact: Moderate, as stores swap out affected stock.
- Brand impact: Limited, if Amgen fixes the packaging process quickly.
Patients taking Corlanor and Sensipar should verify their bottles this week. A two-minute label check is the simplest way to stay safe.
- Amgen Recalls Nearly One Million Heart and Kidney Medication Bottles
- Amy Adams Daughter Stunned Fans With Her Likeness to Johansson
- Aberdeen Father Arrested After Son Found Buried in Yard
- Josh Sanders Faces Serious Intoxication And Violence Allegations Regarding Kids
- JFK Airport Central Taxi Hold 148th Street Queens NY Update